Navigation Links
Imprivata Named One of Modern Healthcare’s Best Places to Work
Date:10/30/2013

ef="http://www.cortext.com/" onclick="linkClick(this.href)" rel="nofollow">secure text messaging solutions that enable providers at healthcare organizations worldwide to quickly and securely access clinical applications and more efficiently communicate and collaborate with care teams for better focus on patient care. Imprivata, recognized as the SSO category leader in the 2012 Best in KLAS Awards report, enables fast, secure No Click Access® to clinical applications to streamline workflows and enable clinicians to maintain focus on patient care. The company's HIPAA-compliant, secure text messaging solution enables clinicians to securely send text and picture messages to improve efficiency, enhance patient care and address the deficiencies of pagers and other outdated communication technologies.

About Imprivata
Imprivata is a leading global provider of healthcare IT solutions that enable fast, secure and more efficient clinical access, communication and collaboration. Independently recognized as an innovator and market leader, Imprivata helps millions of providers worldwide simplify technology to better focus on patient care. For more information, please visit http://www.imprivata.com.

All Imprivata products are trademarks of Imprivata, Inc. in the USA and other countries. All other product or company names mentioned are the property of their respective owners.

# # #

Read the full story at http://www.prweb.com/releases/2013/10/prweb11277623.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. MEDIA ALERT: Imprivata and Dell Wyse to Discuss Benefits of Desktop Virtualization and Single Sign-On in Healthcare at Citrix Synergy
2. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. MEDITECH Customers According to HIMSS Analytics
3. Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review
4. Imprivata Cortext Secure Text Messaging Solution Validated as HIPAA Compliant by ecfirst
5. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. Hospitals Using Siemens Soarian Clinicals according to HIMSS Analytics
6. Imprivata is the Most Widely Selected Single Sign-On Solution by U.S. Hospitals Using McKesson Paragon or Horizon According to HIMSS Analytics
7. Imprivata Named to Modern Healthcare’s List of Healthcare’s Hottest Companies
8. Imprivata Recognized by Inc. Magazine as Top U.S. Job Creator
9. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
10. Dr. William Oh named 2012 Legend of Neonatology
11. UCSC physicist Alexander Sher named Pew Scholar in the Biomedical Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... ... Using the latest online digital technologies, happiness expert Kay Walker is on ... manage major depression. , “Suicide is 100% preventable. The problem is the medical community ... die needlessly everyday,” says Walker. “I’m out to end suicide. Some may say that’s ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... On July ... $2 billion in taxpayer money to fund the state’s large prison system, which has ... with the highest rates of incarceration. In light of President Obama’s recent reduction of ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
(Date:7/30/2015)... ... July 30, 2015 , ... The ... of the New Jersey Department of Health, has received a $2.9 million grant ... of the U.S. Department of Health and Human Services (HHS). NJII will help ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... InventHelp, ... from Texas, has designed a personal-care device that makes it easy to apply lotion ... could eliminate the need for assistance when applying lotion or medication to the back, ...
Breaking Medicine News(10 mins):Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 2Health News:Happiness Expert Develops Pioneering Online Tools for Sufferers of Major Depression, and Who may be Suicidal 3Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... Even non-obese people are at risk, researchers find , WEDNESDAY, ... major risk factor for obstructive sleep apnea, many non-obese people ... new study. , Among 5,426 non-obese adults (with a body-mass ... present in 54 percent. About half of those with the ...
... key target of an evolutionarily conserved protein that regulates ... in Nature , provides fundamental knowledge about key ... strategies and cancer therapies. Scientists have long ... fitness and longevity in most organisms ranging from single-celled ...
... Four suspects often found at the scene of the crime in ... in mice that are resistant to the disease, a team led ... Center reports in the June edition of Cancer Cell . ... the three protein receptors and the enzyme that makes them are ...
... June 10 As more and more employees become eligible ... and smaller percentage of them are actually signing up for ... of the Spencer,s Benefits Reports 2009 COBRA Survey. ... the 2008 plan year at companies covered by the survey, ...
... Seroquel, Zyprexa have been linked to certain health ... News) -- A U.S. Food and Drug Administration ... whether several powerful but controversial antipsychotic drugs be ... in question include new-generation "atypical" antipsychotics such as ...
... Education Newsletter Series for Healthcare Professionals , , ... syndrome characterized by localized, subcutaneous and/or submucosal swelling. Diagnosing ... there are multiple etiologies of this condition, all of ... healthcare professionals to understand the various causes of angioedema, ...
Cached Medicine News:Health News:Wistar Institute team finds key target of aging regulator 2Health News:Researchers identify four new targets for breast cancer 2Health News:Spencer's Benefits Reports COBRA Survey Finds Recession Takes Hold: More Were Eligible, Fewer Signed Up, Costs Stay High 2Health News:Spencer's Benefits Reports COBRA Survey Finds Recession Takes Hold: More Were Eligible, Fewer Signed Up, Costs Stay High 3Health News:Spencer's Benefits Reports COBRA Survey Finds Recession Takes Hold: More Were Eligible, Fewer Signed Up, Costs Stay High 4Health News:FDA Panel Mulls Newer Antipsychotics for Kids 2Health News:FDA Panel Mulls Newer Antipsychotics for Kids 3Health News:FDA Panel Mulls Newer Antipsychotics for Kids 4Health News:New Directions in Angioedema: A Focus on Etiologies and Clinical Approach 2
(Date:7/30/2015)... 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... of the t:slim® and t:flex™ Insulin Pumps, today ... Agreements with Dexcom, Inc. to allow the integration ... Dexcom G5 and G6 continuous glucose monitoring ("CGM") ... platform with Dexcom,s future CGM systems is an ...
(Date:7/30/2015)... OAKS, Calif., July 30, 2015  Amgen (NASDAQ: ... the second quarter of 2015. Key results include: ... the second quarter of 2014 to $5,370 million, ... by Enbrel ® (etanercept), Prolia ® ... (carfilzomib) and XGEVA ® (denosumab). Unfavorable changes ...
(Date:7/30/2015)... WOODCLIFF LAKE, N.J. , July 30, 2015 /PRNewswire/ ... submitted simultaneously in the United States ... (to the FDA, EMA and MHLW, respectively) for eribulin, ... sarcoma (STS) who have received prior chemotherapy for advanced ... are based on data from a pivotal global Phase ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5
... American Pharmacists Month and CVS Caremark is recognizing ... their patients every day in its retail pharmacies, ... country. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) (Logo: ... time to recognize the significant contributions to health ...
... pharmaceutical and biotechnology sectors have long turned to the ... landscape. As the marketplace has evolved, leading organizations have ... as well. Specifically, effective market research groups ... one involved with shaping strategic objectives for key commercial ...
Cached Medicine Technology:CVS Caremark Recognizes Its 26,000 Pharmacists During October's American Pharmacists Month 2Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success 2
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
... are available in 14 configurations including the ... Microgenics Antibody Technology, the SureStep™ MDMA (Ecstasy) ... immunoassay targeted to detect MDMA that has ... but no cross-reactivity to any isomer of ...
The SEDITAINER Erythrocyte Sedimentation Rate (ESR) System is for collection of blood specimens for the measurement of ESR within the blood collection tube, using the SEDITAINER ESR Stand....
... is a quantitative microplate enzyme immunoassay that can ... for rapid recurrence or occult disease. The test ... and is twice as sensitive as urine cytology. ... outcome by identifying those patients who may benefit ...
Medicine Products: